157 related articles for article (PubMed ID: 18460214)
1. Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: a prospective study.
Simopoulos C; Tsaroucha AK; Asimakopoulos B; Giatromanolaki A; Gavriilidis P; Polychronidis A; Karayiannakis A
BMC Gastroenterol; 2008 May; 8():14. PubMed ID: 18460214
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
[TBL] [Abstract][Full Text] [Related]
3. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.
Linder S; Olofsson MH; Herrmann R; Ulukaya E
Expert Rev Mol Diagn; 2010 Apr; 10(3):353-9. PubMed ID: 20370591
[TBL] [Abstract][Full Text] [Related]
4. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin markers come of age.
Linder S
Tumour Biol; 2007; 28(4):189-95. PubMed ID: 17717426
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokeratin 18 as a biomarker for gastric cancer.
Oyama K; Fushida S; Kinoshita J; Okamoto K; Makino I; Nakamura K; Hayashi H; Inokuchi M; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fujimura T; Ohta T
Clin Exp Med; 2013 Nov; 13(4):289-95. PubMed ID: 22825587
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 8 and 18 tissue expression in gallbladder mucosa of patients with cholelithiasis.
Kasprzak A; Malkowski W; Seraszek A; Surdyk-Zasada J; Szmeja J; Rogacki K; Kaczmarek E; Zabel M
Pol J Pathol; 2011 Dec; 62(4):241-9. PubMed ID: 22246910
[TBL] [Abstract][Full Text] [Related]
9. A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients.
Moore DJ; Greystoke A; Butt F; Wurthner J; Growcott J; Hughes A; Dive C
Clin Drug Investig; 2012 Mar; 32(3):179-87. PubMed ID: 22217154
[TBL] [Abstract][Full Text] [Related]
10. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
[TBL] [Abstract][Full Text] [Related]
11. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
Cummings J; Ranson M; Lacasse E; Ganganagari JR; St-Jean M; Jayson G; Durkin J; Dive C
Br J Cancer; 2006 Jul; 95(1):42-8. PubMed ID: 16804528
[TBL] [Abstract][Full Text] [Related]
12. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection.
Balkan A; Yılmaz N; Balkan Y; Koruk I; Örkmez M; Aydınlı M; Koruk M
Arab J Gastroenterol; 2017 Jun; 18(2):98-103. PubMed ID: 28579343
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in the developing human heart resembles apoptosis in epithelial tissues.
Jerše M; Zidar N
Cell Tissue Res; 2011 Mar; 343(3):537-43. PubMed ID: 21274568
[TBL] [Abstract][Full Text] [Related]
14. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
Dive C; Smith RA; Garner E; Ward T; George-Smith SS; Campbell F; Greenhalf W; Ghaneh P; Neoptolemos JP
Br J Cancer; 2010 Feb; 102(3):577-82. PubMed ID: 20051949
[TBL] [Abstract][Full Text] [Related]
15. Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.
Parfieniuk-Kowerda A; Lapinski TW; Rogalska-Plonska M; Swiderska M; Panasiuk A; Jaroszewicz J; Flisiak R
Liver Int; 2014 Apr; 34(4):544-50. PubMed ID: 23981197
[TBL] [Abstract][Full Text] [Related]
16. Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.
Elalfy H; Besheer T; Arafa MM; El-Hussiny MA; El Latif MA; Alsayed SAM
J Gastrointest Cancer; 2018 Sep; 49(3):260-267. PubMed ID: 28361205
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell death products predict clinical outcome of colorectal cancer patients.
Koelink PJ; Lamers CB; Hommes DW; Verspaget HW
BMC Cancer; 2009 Mar; 9():88. PubMed ID: 19302716
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study.
Adebayo D; Morabito V; Andreola F; Pieri G; Luong TV; Dhillon A; Mookerjee R; Jalan R
Liver Int; 2015 Dec; 35(12):2564-74. PubMed ID: 25879577
[TBL] [Abstract][Full Text] [Related]
19. Total Keratin-18 (M65) as a Potential, Early, Non-Invasive Biomarker of Hepatocyte Injury in Alcohol Intoxicated Adolescents-A Preliminary Study.
Zdanowicz K; Olanski W; Kowalczuk-Kryston M; Bobrus-Chociej A; Werpachowska I; Lebensztejn DM
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207346
[TBL] [Abstract][Full Text] [Related]
20. Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis.
Vakkala M; Laurila JJ; Saarnio J; Koivukangas V; Syrjälä H; Karttunen T; Soini Y; Ala-Kokko TI
Crit Care; 2007; 11(5):R116. PubMed ID: 17974017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
